Damage to Polymer of Paclitaxel-Eluting Stent

The polymer of paclitaxel-eluting stents (PES) plays an important role in controlling the release of paclitaxel. Damage to the polymer of a PES that is used in a patient has not been demonstrated, although in-vitro studies report disruption of it. The present case report describes damage to a PES as...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal 2008, Vol.72(11), pp.1907-1908
Main Authors: Kitahara, Hideki, Kobayashi, Yoshio, Yamaguchi, Masashi, Ohkubo, Kenji, Nakayama, Takashi, Kuroda, Nakabumi, Komuro, Issei
Format: Article
Language:English
Subjects:
Angioplasty
Antineoplastic Agents, Phytogenic
Calcinosis - therapy
Coronary artery disease
Coronary Restenosis - therapy
Coronary Vessels - ultrastructure
Drug-Eluting Stents
Graft Occlusion, Vascular - therapy
Humans
Male
Middle Aged
Paclitaxel
Restenosis
Stent
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The polymer of paclitaxel-eluting stents (PES) plays an important role in controlling the release of paclitaxel. Damage to the polymer of a PES that is used in a patient has not been demonstrated, although in-vitro studies report disruption of it. The present case report describes damage to a PES as delivery through a calcified coronary artery was being attempted. (Circ J 2008; 72: 1907 - 1908)
ISSN:1346-9843
1347-4820
DOI:10.1253/circj.CJ-08-0024